Nicotinamide Idi

Nicotinamide, the active ingredient in Nicotinamide Idi, is a Vitamin B3 presented as an oral nutritional supplement for oral use. It is employed to prevent and treat niacin deficiency, support skin health, and provide general nutritional supplementation in adults and children as needed. The product is formulated to meet European Union quality standards and is available over the counter.

GNH USA supplies Nicotinamide Idi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our distribution network ensures reliable delivery to healthcare providers across multiple regions.

Nicotinamide is used to address conditions related to niacin deficiency and skin health, as well as general nutritional needs. - Niacin deficiency: helps restore normal levels of vitamin B3 and prevents symptoms such as pellagra. - Skin health: supports barrier function and may improve appearance of dry or inflamed skin. - General nutritional supplementation: provides an essential nutrient for metabolic processes in individuals with inadequate dietary intake.

Oral nicotinamide is generally well tolerated, but some users may experience adverse reactions.

Common Side Effects: - Nausea: mild stomach upset that usually resolves without intervention, may be lessened by taking with food. - Headache: transient headache reported in a minority of users, often mild and short‑lasting. - Flushing: occasional mild flushing similar to that seen with niacin, typically brief and not painful. - Gastrointestinal discomfort: abdominal cramps, diarrhea or loose stools that generally improve with continued use. - Skin irritation: mild rash or itching at the site of contact, usually resolves after discontinuation.

Serious or Rare Side Effects: - Hepatotoxicity: elevated liver enzymes or liver injury in rare cases, requiring monitoring of hepatic function. - Severe hypersensitivity: anaphylactic reactions with swelling, difficulty breathing, and hives, needing immediate medical care. - Blood disorders: rare cases of thrombocytopenia or leukopenia, presenting with easy bruising or infections. - Metabolic acidosis: extremely rare, associated with very high doses, presenting with rapid breathing and fatigue. - Hyperuricemia: possible increase in uric acid levels leading to gout flare, especially in predisposed individuals.

When using Nicotinamide Idi, certain precautions should be observed to ensure safety and product integrity. - Assess renal function: adjust use in patients with severe renal impairment. - Monitor liver enzymes: periodic testing is advised for long‑term high‑dose therapy. - Avoid excessive alcohol: concurrent heavy alcohol intake may increase liver risk. - Pregnancy and lactation: consult a healthcare professional before use, as safety data are limited. - Drug interactions: review concomitant medications for potential interactions (see interaction section). - Store at ambient temperature: keep below 25 °C, in the original container, protected from moisture and direct sunlight.

Nicotinamide may affect the pharmacokinetics or pharmacodynamics of several medicines; awareness of these interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - Anticonvulsants (e.g., carbamazepine, phenobarbital): may reduce nicotinamide efficacy by increasing metabolism. - High‑dose vitamin B3 (niacin) supplements: combined use can increase risk of liver toxicity. - Chemotherapeutic agents (e.g., methotrexate): potential additive toxicity to liver.

Moderate Interactions (Monitor Closely): - Antihypertensives: nicotinamide may modestly lower blood pressure, requiring dose adjustment. - Antidiabetic drugs: possible enhancement of hypoglycemic effect, monitor glucose levels. - Oral anticoagulants: may affect platelet function, monitor INR or clotting parameters.